US Patent Issued to CURASIGHT on Oct. 20 for "Urokinase plasminogen activator receptor targeted radiolabeled peptide conjugates" (Danish Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,201, issued on Oct. 20, was assigned to CURASIGHT A/S (Copenhagen N, Denmark).

"Urokinase plasminogen activator receptor targeted radiolabeled peptide conjugates" was invented by Andreas Kjaer (Frederiksberg, Denmark), Knud Jorgen Jensen (Copenhagen, Denmark), Jakob Madsen (Skovlunde, Denmark) and Troels Elmer Jeppesen (Copenhagn, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention describes Urokinase Plasminogen Activator Receptor (uPAR) targeted radiolabeled conjugates suited for non-invasive PET imaging, SPECT imaging or targeted radionuclide therapy. In particular, but not limited to, the invention related to imaging and...